These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 38355690)
1. SARS-CoV-2 spike protein-ACE2 interaction increases carbohydrate sulfotransferases and reduces N-acetylgalactosamine-4-sulfatase by p38 MAPK. Bhattacharyya S; Tobacman JK Signal Transduct Target Ther; 2024 Feb; 9(1):39. PubMed ID: 38355690 [TBL] [Abstract][Full Text] [Related]
2. Increase in Chondroitin Sulfate and Decline in Arylsulfatase B May Contribute to Pathophysiology of COVID-19 Respiratory Failure. Tzankov A; Bhattacharyya S; Kotlo K; Tobacman JK Pathobiology; 2022; 89(2):81-91. PubMed ID: 34788765 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF. Bhattacharyya S; Feferman L; Tobacman JK PLoS One; 2016; 11(4):e0153463. PubMed ID: 27078017 [TBL] [Abstract][Full Text] [Related]
4. Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A. Bhattacharyya S; Feferman L; Tobacman JK Biochim Biophys Acta; 2015 Mar; 1849(3):342-52. PubMed ID: 25511584 [TBL] [Abstract][Full Text] [Related]
6. Increased CHST15 follows decline in arylsulfatase B (ARSB) and disinhibition of non-canonical WNT signaling: potential impact on epithelial and mesenchymal identity. Bhattacharyya S; Feferman L; Han X; Xia K; Zhang F; Linhardt RJ; Tobacman JK Oncotarget; 2020 Jun; 11(24):2327-2344. PubMed ID: 32595831 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3. Bhattacharyya S; Feferman L; Tobacman JK J Biol Chem; 2014 Jun; 289(25):17564-75. PubMed ID: 24778176 [TBL] [Abstract][Full Text] [Related]
8. Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells. Bhattacharyya S; Feferman L; Han X; Ouyang Y; Zhang F; Linhardt RJ; Tobacman JK J Biol Chem; 2018 Jul; 293(28):11076-11087. PubMed ID: 29794138 [TBL] [Abstract][Full Text] [Related]
9. Decline in arylsulfatase B and Increase in chondroitin 4-sulfotransferase combine to increase chondroitin 4-sulfate in traumatic brain injury. Bhattacharyya S; Zhang X; Feferman L; Johnson D; Tortella FC; Guizzetti M; Tobacman JK J Neurochem; 2015 Aug; 134(4):728-39. PubMed ID: 25943740 [TBL] [Abstract][Full Text] [Related]
10. Decline in arylsulfatase B leads to increased invasiveness of melanoma cells. Bhattacharyya S; Feferman L; Terai K; Dudek AZ; Tobacman JK Oncotarget; 2017 Jan; 8(3):4169-4180. PubMed ID: 27926479 [TBL] [Abstract][Full Text] [Related]
11. Molecular signature of kappa-carrageenan mimics chondroitin-4-sulfate and dermatan sulfate and enables interaction with arylsulfatase B. Bhattacharyya S; Tobacman JK J Nutr Biochem; 2012 Sep; 23(9):1058-63. PubMed ID: 22079206 [TBL] [Abstract][Full Text] [Related]
12. Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases. Tobacman JK; Bhattacharyya S Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361933 [TBL] [Abstract][Full Text] [Related]
13. Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin. Kotlo K; Bhattacharyya S; Yang B; Feferman L; Tejaskumar S; Linhardt R; Danziger R; Tobacman JK Glycoconj J; 2013 Oct; 30(7):667-76. PubMed ID: 23385884 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of estrogen exposure on arylsulfatase B, galactose-6-sulfatase, and steroid sulfatase in rat prostate development. Feferman L; Bhattacharyya S; Birch L; Prins GS; Tobacman JK J Steroid Biochem Mol Biol; 2014 Sep; 143():105-14. PubMed ID: 24508597 [TBL] [Abstract][Full Text] [Related]
15. Increased Cerebral Serum Amyloid A2 and Parameters of Oxidation in Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase)-Null Mice. Bhattacharyya S; Tobacman JK J Alzheimers Dis Rep; 2023; 7(1):527-534. PubMed ID: 37313486 [TBL] [Abstract][Full Text] [Related]
16. Effect of CFTR modifiers on arylsulfatase B activity in cystic fibrosis and normal human bronchial epithelial cells. Bhattacharyya S; Feferman L; Tobacman JK Pulm Pharmacol Ther; 2016 Feb; 36():22-30. PubMed ID: 26656789 [TBL] [Abstract][Full Text] [Related]
17. Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects. Bhattacharyya S; Feferman L; Tobacman JK Oncogene; 2014 Nov; 33(47):5467-76. PubMed ID: 24240681 [TBL] [Abstract][Full Text] [Related]
18. N-Acetylgalactosamine-4-sulfatase (Arylsulfatase B) Regulates PD-L1 Expression in Melanoma by an HDAC3-Mediated Epigenetic Mechanism. Bhattacharyya S; O-Sullivan I; Tobacman JK Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892038 [TBL] [Abstract][Full Text] [Related]
19. Arylsulfatase B modulates neurite outgrowth via astrocyte chondroitin-4-sulfate: dysregulation by ethanol. Zhang X; Bhattacharyya S; Kusumo H; Goodlett CR; Tobacman JK; Guizzetti M Glia; 2014 Feb; 62(2):259-71. PubMed ID: 24311516 [TBL] [Abstract][Full Text] [Related]
20. Increased Cerebral Serum Amyloid A2 and Parameters of Oxidation in Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase)-Null Mice. Bhattacharyya S; Tobacman JK bioRxiv; 2023 Apr; ():. PubMed ID: 37066366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]